Abstract
Interstitial lung disease (ILD) is a group of diffuse pulmonary diseases primarily affecting the pulmonary interstitium and alveolar spaces, leading to restrictive ventilatory dysfunction and diffusion impairment. Patients with ILD have a higher risk of developing lung cancer, which is an indisputable risk factor for lung cancer. However, the pathogenesis of ILD with lung cancer (ILD-LC) remains unclear, and there are few consensus documents for the specific diagnosis and treatment of ILD-LC to date. This article reviews the latest advancements in the epidemiology, risk factors, pathogenesis, diagnosis, and treatment of ILD-LC, aiming to provide a guide for the treatment of ILD-LC patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
